# Bilateral Optic Neuritis as the Initial Presentation of Acute HIV Infection in a Young Bodybuilder: A Case Report

**Authors:** Jennifer Lu, Kathleen Tor, Joseph Yasmeh, Monique George

PMC · DOI: 10.3390/reports9010052 · Reports - Clinical Practice and Surgical Cases · 2026-02-03

## TL;DR

A young bodybuilder with bilateral optic neuritis was found to have acute HIV infection, showing that optic issues can signal underlying infections.

## Contribution

This case report adds a rare instance of acute HIV presenting as bilateral optic neuritis in a young man with high-risk behaviors.

## Key findings

- Bilateral optic neuritis was diagnosed in a young man with acute HIV-1 infection.
- The patient improved with corticosteroids and antiretroviral therapy.
- The case emphasizes considering HIV in atypical optic neuritis presentations.

## Abstract

Background and Clinical Significance: Optic neuritis, an inflammatory demyelinating condition affecting the optic nerve, can present as an isolated phenomenon or as a harbinger of an underlying systemic disorder. While often associated with multiple sclerosis (MS), optic neuritis has been reported in the context of various infectious and inflammatory conditions, including human immunodeficiency virus (HIV) infection. Case Presentation: We describe a case of bilateral optic neuritis that led to the diagnosis of acute HIV infection in a young man actively engaged in bodybuilding, anabolic steroid use, and high-risk sexual behavior. The patient initially presented with an acute onset of vision loss, headache, and photophobia. Magnetic resonance imaging (MRI) findings confirmed demyelination of the optic nerves, and laboratory workup revealed acute HIV-1 infection. The patient improved following high-dose corticosteroids and initiation of antiretroviral therapy. Conclusions: This case highlights the need to consider systemic infections such as HIV in atypical presentations of optic neuritis.

## Linked entities

- **Diseases:** optic neuritis (MONDO:0005885), HIV infection (MONDO:0005109), multiple sclerosis (MONDO:0005301)

## Full-text entities

- **Genes:** MOG (myelin oligodendrocyte glycoprotein) [NCBI Gene 4340] {aka BTN6, BTNL11, MOGIG2, NRCLP7}, AQP4 (aquaporin 4) [NCBI Gene 361] {aka MIWC, MLC4, WCH4, hAQP4}
- **Diseases:** granulomatous disease (MESH:D006105), autoimmune (MESH:D001327), vascular complications (MESH:D003925), acute human immunodeficiency virus (HIV) infection (MESH:C564112), intracranial stenoses (MESH:D003251), neurologic (MESH:D009461), headache (MESH:D006261), inflammatory (MESH:D007249), papilledema (MESH:D010211), injury to (MESH:D014947), inflammatory demyelination (MESH:D020277), demyelination of the optic nerves (MESH:D000080344), fibromuscular dysplasia (MESH:D005352), cerebral vasoconstriction syndrome (MESH:D002547), cerebral arterial disease (MESH:D002539), inflammatory optic neuropathy (MESH:D009901), blurred vision (MESH:D014786), opportunistic infection (MESH:D009894), endothelial dysfunction (MESH:D014652), IRIS (MESH:D054019), arterial dissection (MESH:D000094665), intracranial arterial disease (MESH:D020765), neurological complications (MESH:D002493), obstructive sleep apnea (MESH:D020181), Moyamoya disease (MESH:D009072), MS (MESH:D009103), fungal (MESH:D009181), immune dysregulation (OMIM:614878), HIV (MESH:D015658), NMOSD (MESH:D009471), sleep apnea (MESH:D012891), migraine (MESH:D008881), systemic disorder (MESH:D009422), infectious (MESH:D003141), hypertriglyceridemia (MESH:D015228), hypertension (MESH:D006973), demyelinating (MESH:D003711), photophobia (MESH:D020795), atherosclerosis (MESH:D050197), viral infection (MESH:D014777), infection (MESH:D007239), intracranial arterial stenosis (MESH:D012078), Bilateral Optic Neuritis (MESH:D009902), neuroretinal disorder (MESH:D012173), vascular injury (MESH:D057772), antiphospholipid antibody syndrome (MESH:D016736), leukocytosis (MESH:D007964)
- **Chemicals:** aspirin (MESH:D001241), methylprednisolone (MESH:D008775), testosterone (MESH:D013739), cholesterol (MESH:D002784), acid (MESH:D000143), oxygen (MESH:D010100), tenofovir alafenamide (MESH:C442442), bictegravir (MESH:C000620396), steroids (MESH:D013256), lipid (MESH:D008055), glucose (MESH:D005947), emtricitabine (-), atorvastatin (MESH:D000069059), rituximab (MESH:D000069283), nandrolone decanoate (MESH:D000077603)
- **Species:** Human immunodeficiency virus 1 (no rank) [taxon 11676], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12922073/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12922073/full.md

## References

19 references — full list in the complete paper: https://tomesphere.com/paper/PMC12922073/full.md

---
Source: https://tomesphere.com/paper/PMC12922073